(S (NP-SBJ Human/JJ CD4/NN lymphocytes/NNS) (ADVP specifically/RB) (VP recognize/VBP (NP (NP a/DT peptide/NN) (VP representing/VBG (NP (NP the/DT fusion/NN region/NN) (PP of/IN (NP (NP the/DT hybrid/NN protein/NN pml\/RAR/NN alpha/NN) (ADJP present/JJ (PP in/IN (NP acute/JJ promyelocytic/JJ leukemia/NN cells/NNS))))))))) ./.)
(S (NP-SBJ (NP Fusion/NN proteins/NNS) (ADJP present/JJ (PP in/IN (NP leukemic/JJ cells/NNS)))) (ADVP-TMP frequently/RB) (VP contain/VBP (NP a/DT new/JJ amino/NN acid/NN) (PP at/IN (NP the/DT fusion/NN point/NN))) ./.)
(S (NP-SBJ We/PRP) (VP tested/VBD (SBAR whether/IN (S (NP-SBJ-51 (NP (NP a/DT peptide/NN) (PRN -LRB-/-LRB- (NP BCR1\/25/NN) -RRB-/-RRB-)) (VP encompassing/VBG (NP (NP the/DT fusion/NN region/NN) (PP of/IN (NP the/DT hybrid/NN molecule/NN pml\/RAR/NN alpha/NN)))) ,/, (SBAR (WHNP-52 which/WDT) (S (NP-SBJ-53 *T*-52/-NONE-) (VP is/VBZ (VP (ADVP selectively/RB) expressed/VBN (NP *-53/-NONE-) (PP by/IN (NP-LGS (NP (NP acute/JJ promyelocytic/JJ leukemia/NN) (PRN -LRB-/-LRB- (NP APL/NN) -RRB-/-RRB-)) cells/NNS)))))) ,/,) (VP can/MD (VP be/VB (VP recognized/VBN (NP *-51/-NONE-) (PP by/IN (NP-LGS human/JJ T/NN lymphocytes/NNS)) (ADVP in/FW vitro/FW))))))) ./.)
(S (NP-SBJ (NP CD4+/JJ lymphocytes/NNS) ,/, (PP at/IN (NP (ADJP-COOD both/CC (ADJP polyclonal/JJ) and/CC (ADJP clonal/JJ)) level/NN)) ,/,) (VP recognized/VBD (NP peptide/NN BCR1\/25/NN) (PP in/IN (NP an/DT HLA-DR--restricted/JJ fashion/NN)) (PP on/IN (NP (NP presentation/NN) (PP-COOD (PP by/IN (NP autologous/JJ (NP (NP antigen-presenting/JJ cell/NN) (PRN -LRB-/-LRB- (NP APC/NN) -RRB-/-RRB-)))) or/CC (PP by/IN (NP (NP APC/NN) (VP expressing/VBG (NP the/DT HLA-DR11/NN restricting/NN molecule/NN)))))))) ./.)
(S (NP-SBJ-54 (NP Control/NN peptides/NNS) (VP corresponding/VBG (PP to/TO (NP the/DT (NP-COOD (NP normal/JJ pml/NN) and/CC (NP RAR/NN alpha/NN)) proteins/NNS)))) (VP were/VBD not/RB (VP recognized/VBN (NP *-54/-NONE-))) ./.)
(S (NP-SBJ (NP One/CD clone/NN) (PRN -LRB-/-LRB- (NP DEG5/NN) -RRB-/-RRB-)) (ADVP also/RB) (VP exerted/VBD (NP (NP a/DT (ADJP-COOD (ADJP high/JJ) and/CC (ADJP specific/JJ)) cytotoxicity/NN) (PP against/IN (NP (NP autologous/JJ cells/NNS) (VP pulsed/VBN (NP */-NONE-) (PP with/IN (NP BCR1\/25/NN))))))) ./.)
(S (NP-SBJ (NP The/DT autologous/JJ DE/NN LCL/NN) (VP-COOD (VP containing/VBG (NP a/DT transduced/VBN pml\/RAR/NN alpha/NN fusion/NN gene/NN)) and/CC (VP expressing/VBG (NP (NP a/DT bcr1/NN type/NN) (PP of/IN (NP the/DT pml\/RAR/NN alpha/NN hybrid/NN protein/NN)))))) (VP induced/VBD (NP (NP the/DT proliferation/NN) (PP of/IN (NP DE/NN anti-BCR1\/25/CD T/NN cell/NN clones/NNS)))) ./.)
(S (NP-SBJ It/PRP) (VP is/VBZ (VP concluded/VBN (SBAR that/IN (S (NP-SBJ (NP the/DT bcr1/NN type-pml\/RAR/NN alpha/NN fusion/NN protein/NN) (PP of/IN (NP APL/NN))) (VP contains/VBZ (NP (NP an/DT antigenic/JJ site/NN) ,/, (UCP-COOD (ADJP absent/JJ (PP from/IN (NP the/DT normal/JJ parent/NN molecules/NNS))) and/CC (VP recognized/VBN (NP */-NONE-) (PP by/IN (NP-LGS human/JJ CD4+/JJ lymphocytes/NNS)))))))))) ./.)
